A new study advances proteomic aging clocks from organs to specific cell types using thousands of plasma proteins from blood samples. Brain astrocyte clocks stand out as strong predictors of Alzheimer's, with extreme old astrocytes tied to a 12.59-fold higher incidence compared to extreme young ones. APOE4 carriers show faster astrocyte aging and elevated disease rates over 15 years. Slow aging in neurons and immune cells links to better long-term survival, while many aged cell types sharply cut 15-year outcomes. This refines how we track and target aging processes across the body. @EricTopol

The new joint AHA-ASCO scientific statement sets a clear framework for defining and selecting cardiovascular endpoints in oncology trials. It moves beyond routine broad testing to mechanism-based assessments that match specific drug risks, improving consistency in safety data. This includes refined MACE definitions, integration of patient-reported outcomes with CTCAE grading, and better use of surrogate markers. Such standardization addresses gaps where cardiovascular events often go underreported. One analysis showed nearly 30 percent of cancer patients have pre-existing cardiovascular disease at diagnosis, highlighting the need for precise trial endpoints. Strong step forward for balancing efficacy and long-term safety. @neerajaiims

The new 2026 AHA/ACC/ADA/ASN guideline frames cardiovascular-kidney-metabolic syndrome as a single progressive condition linking obesity, insulin resistance, diabetes, CKD, and CVD. It introduces a four-stage model for earlier intervention and endorses combined BMI and waist circumference screening to better capture visceral fat risk. PREVENT equations now guide 10- and 30-year CVD risk. GLP-1 therapies gain formal support for event reduction, while SGLT2 inhibitors become first-line in heart failure with mildly reduced or preserved ejection fraction. Multidisciplinary care replaces siloed treatment. One analysis cited in related discussions shows CKM factors drive over 60 percent of cardiovascular events in at-risk adults. Practical shifts like these could alter trajectories for millions. @SaurabhSDani

Tumor metabolism sits at the center of cancer hallmarks, integrating genomic instability, microenvironment dynamics, and phenotypic plasticity to support more effective combination therapies. Recent work highlights how ketone body β-hydroxybutyrate from ketogenic approaches boosts CAR T cell function. In preclinical models, BHB supplementation improved mitochondrial oxidative capacity and led to better tumor control compared with control diets. It also drove epigenetic changes that reduced exhaustion markers. These findings point to practical dietary or supplemental strategies that could enhance existing immunotherapies without complex cell engineering. @NutrioSci

Exercise in type 1 diabetes extends beyond glycemic control by modulating immune responses that drive beta cell damage. A new review outlines how habitual activity and structured training influence cytokine profiles, skeletal muscle uptake, and pancreatic autoimmunity. One analysis of trials showed exercise linked to a moderate reduction in HbA1c levels among youths. These findings support exercise as a practical addition to standard care while results from the EXTOD-Immune HIIT trial are awaited. @a_garciahermoso

Aging steadily weakens immune function and leaves people more exposed to infections, tumors, and poor vaccine responses while driving higher levels of chronic inflammation and autoimmune conditions. The review details how thymic involution and stem cell shifts reduce naive T cell output and promote myeloid bias. By age fifty most adults retain little active thymic tissue, which limits new immune cell production for decades. Targeted restoration of immune resilience could improve healthspan without increasing autoimmunity risk. @EricTopol

Mental disorders represent statistical clusters of interconnected biopsychosocial properties rather than discrete categories. This network approach accounts for the extensive symptom overlap observed in practice, where boundaries between conditions remain fluid. Around 60 percent of individuals with anxiety also experience depressive symptoms, underscoring the value of dimensional models over rigid classifications. Such frameworks better inform personalized assessment and treatment by focusing on shared mechanisms across traits, stressors, and health factors. They align with real world patterns and could refine diagnostic precision moving forward. @JAMAPsych

The modern SAT and ACT have become weaker proxies for high-level intelligence. A survey of verified high-ability individuals shows perfect 1600 scores now plateau around 130-138 FSIQ, with top scores appearing from the 120-125 range upward. This contrasts with the pre-1994 SAT ceiling near 166 IQ. Correlation with FSIQ sits at a range-corrected 0.70, solid yet lower than historical benchmarks like 0.82. Self-reports and modest sample size warrant caution, but the data indicate reduced g-loading at the extremes. @CognitiveMetric

Plasma proteomic clocks from blood now track aging across more than 40 cell types at different rates. The Wyss-Coray study in Nature Medicine identifies how these clocks reveal asynchronous aging. Extreme astrocyte aging predicts Alzheimer's incidence with a hazard ratio of 12.59. Youthful profiles in neuronal and immune cells connect to longer survival. The derived polycellular aging risk score stratifies 15-year mortality risk effectively across multiple cohorts. It links specific cell type aging to higher risks for conditions including ALS, diabetes, and cancer. This work advances precision aging assessment from broad organ level measures to detailed cellular resolution in a blood-based test. @EricTopol

Elite soccer players have cognitive abilities that surpass population averages. A 2025 PNAS study of 204 elite athletes from Brazil and Sweden found they outperformed controls on working memory tasks, cognitive flexibility, planning efficiency in the Tower of Hanoi, and reaction time. Their Big Five traits showed elevated conscientiousness, extraversion, and openness with lower neuroticism. Machine learning reached 97 percent accuracy distinguishing them from non players. These mental advantages predict stronger on field metrics such as goals and successful dribbles. Selection and intense training sharpen these edges. @calotonterias

Morning chronotypes among obese adults show stronger adherence to the EAT-Lancet planetary health diet along with lower inflammation and better psychological well-being than evening types. The cross sectional data links higher morningness scores on the MEQ to improved diet quality and reduced CRP levels. Evening types meanwhile recorded higher BMI and waist measures with weaker alignment to sustainable eating patterns. These patterns suggest chronotype awareness could inform targeted nutrition strategies in obesity management. Results add to evidence on how daily rhythms influence metabolic and mental health markers. @heniek_htw

NEJM reported phase 3 results from the HAELO trial of lonvo-z, an in vivo CRISPR therapy for hereditary angioedema. A single intravenous infusion of this investigational treatment targeting the KLKB1 gene produced an 87 percent reduction in mean monthly attack rate compared with placebo over six months. Treated patients reached near zero attacks while the placebo group stayed elevated. Sixty two percent of those who received lonvo-z remained attack free and needed no further therapy during the period. Crossover patients showed the same rapid drop after switching to active treatment. The effect appeared durable from the first dose onward. This marks a concrete step toward approved one time gene editing options for HAE patients. @NEJM

Vitamin K2 supplementation reduces progression of coronary artery calcification in patients with symptomatic coronary artery disease. In the VitaK-CAC randomized trial patients taking 360 micrograms of MK-7 daily saw their CAC scores rise from 135 to 184 Agatston units over two years compared with an increase from 145 to 214 in the placebo group. The difference remained significant after adjustments. This adds to evidence on vascular health mechanisms though longer studies on clinical events are still needed before broad recommendations. Results align with prior data on matrix Gla protein activation. @DoctorTro

Oral semaglutide 25 mg delivered strong results in the OASIS 4 trial for adults with overweight or obesity. Early responders reached 21.6 percent weight loss at 64 weeks, with gains in physical function scores clearest among those starting from lower baselines. Side effects stayed mostly mild to moderate and did not drive the weight reduction. These outcomes position the oral option as competitive on both efficacy and daily convenience against newer orals in development.

The Nature paper maps conserved transcriptomic signatures of ageing across more than 11,000 samples from mouse, rat, macaque, and human tissues. It identifies shared programs in inflammation, metabolism, extracellular matrix remodeling, and stress responses that predict chronological age and mortality risk more reliably than isolated markers. Slavov highlights how the work integrates data across species and organs yet still leaves open questions on protein-level mechanisms and causal drivers. Functional validation through targeted perturbations will determine which of these patterns can be slowed or reversed. @slavov_n

Skeletal muscle functions as the body's largest endocrine organ. During exercise it releases over 650 identified myokines that drive improvements in neuroplasticity, insulin sensitivity, mitochondrial efficiency, vascular function, immune response, and repair processes across organ systems. Executives focused on performance should view training sessions as targeted molecular interventions rather than simple physical activity. Consistent muscle contractions produce these signaling molecules that create widespread benefits far beyond calorie burn or strength gains. The data supports prioritizing regular movement for measurable health outcomes at the cellular level. @louisanicola_

Poor quality jobs harm health and raise stress levels more than remaining unemployed. The UK Household Longitudinal Study followed over 1100 adults and found that those moving into poor quality work showed allostatic load levels 1.5 times higher than those who stayed jobless. This pattern held across multiple biomarkers including inflammation and metabolic markers even after adjusting for prior health. Focusing on job conditions rather than rushing back into any role supports better long term wellbeing.

Creatine is known for building muscle and improving athletic performance. A new UCLA study just found it does something completely different—it powers the immune cells that direct your body's cancer-fighting response. Researchers published the findings in iScience after studying both mouse models and human cells. The discovery builds on earlier work showing creatine fuels killer T cells that attack tumors directly. Now they've found creatine also energizes dendritic cells—the immune cells that capture tumor fragments and train T cells where to strike. Most cancer immunotherapies target killer T cells directly, but only 20-40% of patients respond. The limitation isn't the T cells themselves. It's the dendritic cells upstream that activate and direct them. The research team started by examining which metabolic genes were most active in dendritic cells that had infiltrated tumors in mice. One gene stood out: the creatine transporter, which pulls creatine into cells. It was markedly elevated in tumor-infiltrating dendritic cells compared to those in healthy tissue. To test whether this mattered, they engineered dendritic cells that couldn't transport creatine. These cells showed impaired survival, reduced activation, and weakened ability to prime T cells for tumor response. When grown alongside T cells in a lab dish, those T cells divided less and produced fewer cancer-fighting signaling molecules. Then they tested the opposite intervention—increasing creatine instead of removing it. Daily creatine injections in melanoma-bearing mice significantly slowed tumor growth and boosted both the number and activation of dendritic cells infiltrating tumors. The creatine-treated dendritic cells produced higher levels of chemical signals that recruit additional immune cells to the tumor site. Metabolomics analysis revealed the mechanism: creatine supplementation raised intracellular ATP levels in dendritic cells. ATP is the energy currency cells use to power nearly every function. Creatine acts like a battery—storing and releasing energy on demand, helping dendritic cells maintain stable energy levels even when competing with fast-growing tumor cells for nutrients. The effect extended to human cells. Creatine treatment enhanced activation of human monocyte-derived dendritic cells—the type often used in dendritic cell cancer vaccines—and improved their ability to stimulate human T cells against cancer-associated targets. The findings suggest incorporating creatine during manufacturing of dendritic cell vaccines may boost their therapeutic potency. More broadly, they reveal that creatine doesn't just help the immune cells fighting cancer directly—it energizes the infrastructure that supports and guides them. Immuotherapy works for some patients but fails for most. The difference may come down to whether dendritic cells can maintain enough energy to properly activate the T cell response. Creatine supplementation addresses that metabolic constraint. A supplement taken by millions for muscle growth and athletic performance turns out to support immune cell function at a fundamental metabolic level—powering both the killer T cells that attack tumors and the dendritic cells that train them where to go.

Multi-marathoners maintain substantially higher VO2max levels than age-matched norms. A 2026 study of 340 runners averaging 121 lifetime marathons found values often exceeding the 95th percentile across age groups, with slower decline rates than population averages. This endurance volume correlates with cardiorespiratory gains that modeling links to lower mortality risk. Self-reported data and wearables limit causal claims, yet the pattern holds after accounting for selection effects. Consistent high-mileage training appears to preserve aerobic capacity better than sporadic activity. @nick_krontiris

Vigorous exercise before a stressor can blunt the cortisol response according to research. A 2021 study in Psychoneuroendocrinology found that 30 minutes of vigorous activity at around 70 percent max effort cut the cortisol rise by 50 to 75 percent. It also lowered the peak level and sped up recovery by roughly 10 minutes. The effect was dose dependent with higher intensity workouts showing the strongest protection against psychosocial stress. This approach offers a practical way to build daily resilience when timed in the morning. @AntelmPujol